MIA:


  • WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
  • WHO ATC Second Level (Therapeutic subgroup) ID: J04 ANTIMYCOBACTERIALS
  • WHO ATC Third Level (Pharmacological subgroup) ID: J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
  • WHO ATC Fourth Level (Chemical subgroup) ID: J04AB Antibiotics
  • WHO ATC Fifth Level (Chemical substance) ID: J04AB05 Rifapentine

  • Chemical Name: Rifapentine
  • Chemical Smi: CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C4CCCC4)c(c(c2c(c3C)O)O)NC(=O)/C(=C\\C=C\\[C@@H]([C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]1C)OC(=O)C)C)O)C)O)C)/C

  • WHO ICD Mapped Level : A28 A28 Name: Other zoonotic bacterial diseases, not elsewhere classified
  • WHO ICD Fourth Level ID: Name:
  • WHO ICD Third Level ID: A28 A28 Name: Other zoonotic bacterial diseases, not elsewhere classified
  • WHO ICD Second Level ID: A20-A28 A20-A28 Name: Certain zoonotic bacterial diseases
  • WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases